Home/Tag: Medical Errors

Tag: Medical Errors

Warning Wire

Latino Death Rate in L.A. Skyrockets; National Masking Order Issued for Public Transportation

The death rate for Latinos in Los Angeles is almost triple that of white residents. Also: a fraud doctor sentenced, Google pays for discrimination, heatwave deaths spike in Arizona, scientists find sea lion cancer culprit, and more.

Warning Wire

EPA Bypassed Ethics Rules in Picks for Science Panels, Government Watchdog Finds

New members of EPA science advisory panels, including some with industry ties, were not not properly screened for ethical conflicts, according to the Government Accountability Office.

Warning Wire

It’s Good for the Planet and Good for the Soul, But Recycling is in Crisis

Now that China has banned imports of certain types of plastic and paper waste, thousands of tons of recyclables in some cities are being hauled to landfills. It's a big issue with no easy solution.

Warning Wire

Dangerous Drug-Resistant Infections on the March

Drug-resistant infections are spreading across the globe and perhaps in a hospital near you. But it may be a secret.

Warning Wire

Coca-Cola Sweet-Talks the CDC

Emails obtained by public health researchers reveal how world’s top maker of sugar-sweetened beverages seeks to bend government policymaking.

Consumer Protection

With Smack-Talking Invective, Lawyer Groups Appeal to Public as One Big Jury Pool

Business groups that howl about bogus lawsuits and plaintiff lawyers who claim to fight for ordinary folks victimized by corporations engage in a war of words.

Warning Wire

U.S. Life Expectancy Fell in 2017, With Drug Overdoses and Suicides the Main Culprits

After decades of improvement, life expectancy has trended downward for three years, the worst reversal in a century.

Warning Wire

Long-Running Government Study Finds Cellphone Radiation Causes Cancer in Rats

Despite federal assurance that the research doesn't apply to people, critics say the results raise health concerns for children and others.


With Rise in Chemotherapy for Pets, Higher Risks for Veterinary Staff

As more dogs and cats are treated for cancer, veterinarians and their assistants increasingly face the risk of exposure to hazardous drugs, which are often being handled without proper safeguards.

Warning Wire

A Foodborne Parasite on the Rise

The U.S. Centers for Disease Control and Prevention has documented 2,173 cases of the foodborne illness cyclosporiasis from May through August this year. That's a surge in the case count from prior years.

Warning Wire

VA Uses an Old Trick at Failing Nursing Homes: Hide the Report Card

Bad grades? What bad grades?:  Nearly half of all Department of Veterans Affairs nursing homes received the agency's lowest possible quality ratings as of December. But until very recently that information was hidden from families looking for a home for their loved ones, an investigation by The Boston Globe and [...]

Consumer Protection

First Amendment Claims Seen as Rx for Drug Makers, Headache for Consumers

On Oct. 26, 2005, Alfred Caronia, a sales consultant for a little-known pharmaceutical company based in California, met with a doctor to discuss promotion of one of the firm’s  drugs. The drug, a depressant called Xyrem, had been approved by the U.S. Food and Drug Administration to treat only certain [...]

Consumer Protection

Johnson & Johnson Hit With Record Talc-Ovarian Cancer Verdict of $417 Million

It was the first California trial in the mushrooming legal battle over links between genital use of talc and ovarian cancer, and the award against J&J was by far the largest so far.

Consumer Protection

Johnson & Johnson Wins Its First Talc-Ovarian Cancer Case

Breaking a string of lopsided courtroom defeats, Johnson & Johnson scored a legal victory Friday when a St. Louis jury rejected the claim of an ovarian cancer victim that her use of talc powders for feminine hygiene caused the disease.

Consumer Protection

Drug Companies Pony Up in Illegal Marketing Cases, But Critics Wonder if Penalties are Enough

Since 1991, unlawful promotion of drugs for off-label use cases have accounted for about $11 billion of a total of more than $35 billion in drug companies' civil and criminal settlements.